Document is current

Any future updates will be listed below

From ICI to ICU: Ipilimumab and Nivolumab-Induced Immune Checkpoint Inhibitor Colitis

Crossref DOI link: https://doi.org/10.1007/s10620-021-07100-4

Published Online: 2021-06-22

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark